Synthesis and Molecular Properties of Nerve Agent Reactivator HLo-7 Dimethanesulfonate.
Hsu, F.L., Bae, S.Y., McGuire, J., Anderson, D.R., Bester, S.M., Height, J.J., Pegan, S.D., Walz, A.J.(2019) ACS Med Chem Lett 10: 761-766
- PubMed: 31097996 
- DOI: https://doi.org/10.1021/acsmedchemlett.9b00021
- Primary Citation of Related Structures:  
6NEA - PubMed Abstract: 
The threat of a deliberate release of chemical nerve agents has underscored the need to continually improve field effective treatments for these types of poisonings. The oxime containing HLö-7 is a potential second-generation therapeutic reactivator. A synthetic process for HLö-7 is detailed with improvements to the DIBAL reduction and ion exchange steps. HLö-7 was visualized for the first time within the active site of human acetylcholinesterase and its relative ex vivo potency confirmed against various nerve agents using a phrenic nerve hemidiaphragm assay.
Organizational Affiliation: 
United States Army Edgewood Chemical Biological Center, Aberdeen Proving Ground, Maryland 21010, United States.